Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)

European Journal of Cancer

Volumn 48, Issue 3, 2012, Pages 377-384

  Pesce, Gianfranco A ^a   Klingbiel, Dirk ^b   Ribi, Karin ^c   Zouhair, Abderahim ^d   Von Moos, Roger ^e   Schlaeppi, Marc ^f   Caspar, Clemens B ^g   Fischer, Natalie ^h   Anchisi, Sandro ⁱ   Peters, Solange ^d   Cathomas, Richard ^e   Bernhard, Jürg ^c   Kotrubczik, Nina M ^j   D'Addario, Giannicola ^f   Pilop, Christiane ^b   Weber, Damien C ^k   Bodis, Stephan ^j   Pless, Miklos ^l   Mayer, Michael ^b   Stupp, Roger ^d  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

^c Quality of Life Office   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^g Kantonsspital Baden   (Switzerland)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ Spital Wallis   (Switzerland)

^j CANTONAL HOSPITAL AARAU   (Switzerland)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^l CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

more..

Author keywords

Brain metastases; Cognitive function; Gefitinib; Non small cell lung cancer; Quality of life; Temozolomide; Whole brain radiotherapy

Indexed keywords

GEFITINIB; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COGNITION; CORTICOSTEROID THERAPY; DIARRHEA; DYSPNEA; FATALITY; FATIGUE; FEMALE; HUMAN; INTESTINE PERFORATION; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; LYMPHOCYTOPENIA; MALE; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; SIDE EFFECT;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; BRIEF PSYCHIATRIC RATING SCALE; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; COGNITION; CRANIAL IRRADIATION; DACARBAZINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUINAZOLINES; SURVIVAL ANALYSIS;

EID: 84856235127     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.10.016     Document Type: Article

References (20)

1. J. Chang Thoracic tumors C.A. Perez, L.W. Brady, Principles and practice of radiation oncology 2008 Lippincott and Williams 1078 1108
2. J.B. Posner Neurologic complications of cancer 1995 Davies FA editors Philadelphia
3. L. Gaspar, C. Scott, and M. Rotman Et al: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 1997 745 751 (Pubitemid 27181303)
4. M. Kocher, R. Soffietti, and U. Abacioglu Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 Study J Clin Oncol 29 2010 134 141
5. G.M. Videtic, L.E. Gaspar, and A.M. Aref American College of Radiology appropriateness criteria on multiple brain metastases Int J Radiat Oncol Biol Phys 75 2009 961 965
6. M.N. Tsao, N. Lloyd, and R. Wong Whole brain radiotherapy for the treatment of multiple brain metastases Cochrane Database Syst Rev 3 2006 CD003869
7. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996 (Pubitemid 40349501)
8. C.S. Adonizio, J.S. Babb, and C. Maiale Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patients Clin Lung Cancer 3 2002 254 258 (Pubitemid 34752670)
9. D. Antonadou, M. Paraskevaidis, and G. Sarris Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases J Clin Oncol 20 2002 3644 3650 (Pubitemid 34983224)
10. D. Antonadou, N. Coliarakis, and M. Paraskevaidis Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. A phase III study Int J Radiat Oncol Biol Phys 54 Suppl. 2002 93 94 [abstract]
11. K. Kelly Huang C: Biological agents in non-small cell lung cancer: a review of recent advances and clinical results with a focus on epidermal growth factor receptor and vascular endothelial growth factor J Thorac Oncol 3 2008 664 673 (Pubitemid 351787316)
12. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
13. G.L. Ceresoli, F. Cappuzzo, and V. Gregorc Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial Ann Oncol 15 2004 1042 1047 (Pubitemid 39089780)
14. J. Bernhard, R. Maibach, and B. Thurlimann Patients' estimation of overall treatment burden: why not ask the obvious? J Clin Oncol 20 2002 65 72 (Pubitemid 34032597)
15. C. Hurny, J. Bernhard, and M. Bacchi The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG) Support Care Cancer 1 1993 200 208
16. J.A. Sloan Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions COPD 2 2005 57 62 (Pubitemid 40776224)
17. D. Chua, M. Krzakowski, and C. Chouaid Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study Clin Lung Cancer 11 2010 176 181
18. E. Verger, M. Gil, and R. Yaya Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial Int J Radiat Oncol Biol Phys 61 2005 185 191 (Pubitemid 40039121)
19. S. Ma, Y. Xu, and Q. Deng Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population Lung cancer 65 2009 198 203
20. R. Addeo, M. Caraglia, and V. Faiola Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life BMC Cancer 7 2007 18